MedPath

Role of Curcumin and Spirulina in restricted mouth opening.

Phase 2
Conditions
Health Condition 1: K135- Oral submucous fibrosis
Registration Number
CTRI/2023/11/059790
Lead Sponsor
Dr. Sanika Vaje
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients with history of areca nut chewing or any other tobacco related product.

2. Clinically diagnosed as OSMF(stage I and stage II) according to Nagesh and Bailoor.

3. Patients who are willing to participate in the study.

4. No history of prior treatment for the same.

Exclusion Criteria

1. Patients who did not give consent for participation.

2. Patients suffering from hypertension, diabetes or any cardiac, respiratory, renal, and hepatic disease.

3. Pregnant women and lactating mothers.

4. History of hypersensitivity to turmeric, spirulina or other antioxidants.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Burning Sensation <br/ ><br>2. Mouth openingTimepoint: 1. Burning Sensation and pain- will be recorded by VAS score after every 15 days for 3 months. <br/ ><br>2. Mouth opening- will be recorded by geometric scale after every 15 days for 3 months.
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath